DrugPatentWatch Database Preview
Litigation Details for Intercept Pharmaceuticals, Inc. v. Apotex Inc. (D. Del. 2020)
Email this page to a colleague
Intercept Pharmaceuticals, Inc. v. Apotex Inc. (D. Del. 2020)
| Docket | ⤷ Try it Free | Date Filed | 2020-08-21 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
| Jury Demand | None | Referred To | |
| Parties | DR. REDDY'S LABORATORIES, LTD.; LUPIN LIMITED | ||
| Patents | 10,047,117; 10,052,337; 10,174,073; 7,138,390; 9,238,673 | ||
| Attorneys | Jeremy A. Tigan; Megan C. Haney | ||
| Firms | Morris, Nichols, Arsht & Tunnell; Schiff Hardin LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Intercept Pharmaceuticals, Inc. v. Apotex Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Try it Free .
Details for Intercept Pharmaceuticals, Inc. v. Apotex Inc. (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-11-12 | 15 | Complaint - Amended | expiration of U.S. Patent Nos. 9,238,673 (filed June 17, 2013) (“the ’673 patent”); 10,047,117 (filed Nov. …Notification of Certification for U.S. Patent Nos. 9,238,673; 10,047,117; 10,052,337; and 10,174,073 (NDA … ’073 patent”); 10,758,549 (filed Feb. 11, 2020) (“the ’549 patent”) (collectively the “patents-in-suit… 1. This action for patent infringement, brought pursuant to the patent laws of the United States…20, 2015) (“the ’117 patent”); 10,052,337 (filed Apr. 26, 2016) (“the ’337 patent”); 10,174,073 (filed | External link to document |
| 2020-11-12 | 16 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s): 9,238,673 B2; 10,047,117 B2; 10,052,… 21 August 2020 1:20-cv-01105 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2020-08-21 | 3 | Patent/Trademark Report to Commissioner of Patents | Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,238,673 B2 ;10,047,117 B2 ;10,052,… 21 August 2020 1:20-cv-01105 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2021-03-03 | 35 | Complaint - Amended | 17, 2013) (“the ’673 patent”); 10,047,117 (filed Nov. 20, 2015) (“the ’117 patent”); 10,052,337 (filed…Notification of Certification for U.S. Patent Nos. 9,238,673; 10,047,117; 10,052,337; and 10,174,073 (NDA …’390 Patent”) prior to filing the Apotex ANDA. The RE286 Patent is a reissue of the ’390 Patent and, … 1. This action for patent infringement, brought pursuant to the patent laws of the United States… expiration of U.S. Patent Nos. RE48,286 (filed June 21, 2019) (“the RE286 Patent”); 9,238,673 (filed | External link to document |
| 2021-03-03 | 36 | Patent/Trademark Report to Commissioner of Patents | ,758,549; 9,238,673; 10,047,117; 10,052,337; 10,174,073. (Blumenfeld, Jack) Modified on 3/4/2021 (dlw)…AMENDED Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE48,286; 10,758,549… 21 August 2020 1:20-cv-01105 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
